Robin Osterman1, Daniel Lewis2, Theresa Winhusen2. 1. University of Cincinnati College of Nursing, 3110 Vine Street, Cincinnati, OH 45219, USA. Electronic address: robin.osterman@uc.edu. 2. Addiction Sciences Division, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA.
Abstract
BACKGROUND: Approximately 35% of pregnant substance users in treatment report alcohol abuse, which increases the risk of fetal alcohol spectrum disorders (FASD) in their offspring. The present study was a preliminary evaluation of the efficacy of motivational enhancement therapy (MET) in decreasing alcohol use in pregnant women attending substance use treatment. METHODS: Secondary analysis of a trial evaluating the efficacy of MET, relative to treatment as usual (TAU), in improving treatment outcomes in 200 pregnant substance users. The present study included the 41 women (n=27 MET and n=14 TAU) who reported alcohol use in the 28days prior to randomization. Alcohol and illicit-drug use days were assessed with self-report; illicit drug use was assessed with urine drug screens. All measures were obtained weekly for the 4week active study phase and at 1 and 3month follow-ups. RESULTS: Significant treatment-by-time interaction effects were found for illicit-drug use days during the active (X2=6.89, df=1, p<0.01) and follow-up (X2=8.26, df=1, p<0.01) phases and for alcohol use during the follow-up phase (X2=13.07, df=1, p<0.001), all reflecting a beneficial effect for MET, relative to TAU. All other treatment effects were non-significant. CONCLUSIONS: These findings suggest that MET may be effective in decreasing alcohol and illicit-drug use in pregnant substance users reporting alcohol use. With 2-5% of US births affected by FASD, future research to replicate these findings seems warranted. TRIAL REGISTRATION: ClinicalTrials.gov http://www.clinicaltrials.gov; Identifier: NCT00078143.
RCT Entities:
BACKGROUND: Approximately 35% of pregnant substance users in treatment report alcohol abuse, which increases the risk of fetal alcohol spectrum disorders (FASD) in their offspring. The present study was a preliminary evaluation of the efficacy of motivational enhancement therapy (MET) in decreasing alcohol use in pregnant women attending substance use treatment. METHODS: Secondary analysis of a trial evaluating the efficacy of MET, relative to treatment as usual (TAU), in improving treatment outcomes in 200 pregnant substance users. The present study included the 41 women (n=27 MET and n=14 TAU) who reported alcohol use in the 28days prior to randomization. Alcohol and illicit-drug use days were assessed with self-report; illicit drug use was assessed with urine drug screens. All measures were obtained weekly for the 4week active study phase and at 1 and 3month follow-ups. RESULTS: Significant treatment-by-time interaction effects were found for illicit-drug use days during the active (X2=6.89, df=1, p<0.01) and follow-up (X2=8.26, df=1, p<0.01) phases and for alcohol use during the follow-up phase (X2=13.07, df=1, p<0.001), all reflecting a beneficial effect for MET, relative to TAU. All other treatment effects were non-significant. CONCLUSIONS: These findings suggest that MET may be effective in decreasing alcohol and illicit-drug use in pregnant substance users reporting alcohol use. With 2-5% of US births affected by FASD, future research to replicate these findings seems warranted. TRIAL REGISTRATION: ClinicalTrials.gov http://www.clinicaltrials.gov; Identifier: NCT00078143.
Authors: Philip A May; J Phillip Gossage; Wendy O Kalberg; Luther K Robinson; David Buckley; Melanie Manning; H Eugene Hoyme Journal: Dev Disabil Res Rev Date: 2009
Authors: R Louise Floyd; Mark Sobell; Mary M Velasquez; Karen Ingersoll; Mary Nettleman; Linda Sobell; Patricia Dolan Mullen; Sherry Ceperich; Kirk von Sternberg; Burt Bolton; Kenneth Johnson; Bradley Skarpness; Jyothi Nagaraja Journal: Am J Prev Med Date: 2007-01 Impact factor: 5.043
Authors: Philip A May; Amy Baete; Jaymi Russo; Amy J Elliott; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; Omar Abdul-Rahman; Margaret P Adam; Luther K Robinson; Melanie Manning; H Eugene Hoyme Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Kathleen M Carroll; Samuel A Ball; Charla Nich; Steve Martino; Tami L Frankforter; Christiane Farentinos; Lynn E Kunkel; Susan K Mikulich-Gilbertson; Jon Morgenstern; Jeanne L Obert; Doug Polcin; Ned Snead; George E Woody Journal: Drug Alcohol Depend Date: 2005-09-28 Impact factor: 4.492
Authors: H Eugene Hoyme; Philip A May; Wendy O Kalberg; Piyadasa Kodituwakku; J Phillip Gossage; Phyllis M Trujillo; David G Buckley; Joseph H Miller; Alfredo S Aragon; Nathaniel Khaole; Denis L Viljoen; Kenneth Lyons Jones; Luther K Robinson Journal: Pediatrics Date: 2005-01 Impact factor: 7.124